Roche sues Biocon and Mylan over biosimilar version of Herceptin in India
7th March, 2014 - 12:31 pm
Categories:
IP Practice in India
IPAB Decisions
News & Updates
Patents
0 Comments
Trastuzumab/Herceptin has been amidst several controversaries off lately and this time it is regarding a biosimilar which has jointly been manufactured by Biocon and Mylan. Background Roche’s breast cancer drug Herceptin sold under the brand names HERCEPTIN, HERCLONTM and BICELTIS is a biological drug used primarily for the treatment for human epidermal growth factor receptor … Continue reading Roche sues Biocon and Mylan over biosimilar version of Herceptin in India
Read more »